Foundation Medicine
Foundation Medicine raises $100M Series D at $1B valuation
Quick Facts
Foundation Medicine: Series D Funding Round
Foundation Medicine has successfully raised $100M in Series D funding, reaching a valuation of $1B.
Company Overview
Genomic profiling for cancer treatment
Funding Details
The Series D round was led by Third Rock Ventures, with participation from Google Ventures.
Company Information
- Headquarters: Cambridge, MA
- Founded: 2010
- Employees: 1000+
- Category: Biotech
Investment
Foundation Medicine plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Third Rock Ventures: Verified investor in Series D
- Google Ventures: Verified investor in Series D
Key Investors
About the Author
Related Company Reports
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
